TherapeuticsMD (TXMD)
NASDAQ:TXMD

TherapeuticsMD (TXMD) Cash flow

2,221 Followers

TherapeuticsMD Cash Flow

TXMD's free cash flow for Q3 2023 was $-6.03M. For the 2023 fiscal year, TXMD's free cash flow was decreased by $-32.44M and operating cash flow was $-6.03M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 55.09M$ -50.72M$ 9.36M$ -408.22M$ -159.47M$ -165.70M
Investing Cash Flow
$ -142.67M-$ -355.00K$ -2.22M$ -1.60M$ -23.91M
Financing Cash Flow
$ -128.80M$ 3.15M$ -235.21M$ 129.55M$ 80.72M$ 188.83M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 154.60M$ 1.75M$ 64.91M$ -200.40M$ 80.49M$ 160.83M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 5.17M-$ 13.54M$ 25.07M$ 25.85M$ 17.79M
Issuance Of Capital Stock
$ 1.15M$ 3.15M$ 2.45M$ 184.12M$ 31.70M$ 77.03M
Issuance Of Debt
$ -114.48M-$ -219.43M$ -50.00M$ 50.00M$ 200.00M
Repayment Of Debt
$ -94.43M-$ -219.43M$ -50.00M$ 0.00$ -81.66M
Free Cash Flow
$ 58.44M$ -23.08M$ 9.36M$ -410.44M$ -161.07M$ -189.59M
Domestic Sales
------
Foreign Sales
------
Currency in USD

TherapeuticsMD Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis